Scientific article


Published inRevue médicale suisse, vol. 1, no. 1, p. 39-42
Publication date2005

Alternative to nephrotoxic calcineurin inhibitors regimens are feasible in renal transplantation. Sirolimus is an effective immunosuppressive drug with less drug-induced nephrotoxicity. Enteric-coated mycophenolate sodium provides a safety and efficacy alternative to mycophenolate mofetil. In peritoneal effluent, cancer antigen 125 (Ca 125) is a mesothelial cell marker and of in vivo biocompatibility of the new dialysis solutions. Longterm PD and peritoneal sclerosis are associated with a low number of mesothelial cells and a low concentration of dialysate Ca 125. Exposure to glucose and degradation products (GDPs) is important in the genesis of mesothelial damage. Short results of the more biocompatible solutions are promising (increasing of Ca 125). In the future, exposure to glucose can be reduced by using combinations of various osmotic agents, each in a low concentration (glycerol and amino acid solution).

  • Humans
  • Immunosuppressive Agents/therapeutic use
  • Kidney Diseases/therapy
  • Kidney Transplantation
  • Mycophenolic Acid/therapeutic use
  • Peritoneal Dialysis
  • Sirolimus/therapeutic use
Citation (ISO format)
MARANGON, Nicola Danièle Armando et al. Néphrologie. In: Revue médicale suisse, 2005, vol. 1, n° 1, p. 39–42.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation08/18/2014 3:01:00 PM
First validation08/18/2014 3:01:00 PM
Update time03/14/2023 9:31:48 PM
Status update03/14/2023 9:31:47 PM
Last indexation01/16/2024 11:37:24 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack